GSA CAPITAL PARTNERS LLP - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 184 filers reported holding NPS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$540,000
-55.8%
15,100
-67.9%
0.04%
-40.6%
Q3 2014$1,222,000
+10.9%
47,018
+41.0%
0.06%
+28.0%
Q2 2014$1,102,000
-39.5%
33,337
-45.2%
0.05%
-61.5%
Q1 2014$1,821,000
+89.7%
60,846
+92.4%
0.13%
+71.1%
Q4 2013$960,000
-14.4%
31,625
-10.3%
0.08%
-14.6%
Q3 2013$1,121,000
+39.1%
35,251
-33.9%
0.09%
-7.3%
Q2 2013$806,00053,3290.10%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2013
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders